Literature DB >> 8207344

In situ-forming gels for ophthalmic drug delivery.

S Kumar1, B O Haglund, K J Himmelstein.   

Abstract

Poor bioavailability of ophthalmic solutions caused by dilution and drainage from the eye can be overcome by using in situ-forming ophthalmic drug delivery systems prepared from polymers that exhibit reversible phase transitions. Joshi et al. (1), have demonstrated that aqueous compositions that reversibly gel in response to simultaneous variations in at least two physical parameters, such as temperature, pH, and ionic strength, can be formed by appropriate combinations of macromolecular polymers which exhibit reversible gelation properties. In the present study, the rheological characterization of such a system, prepared by a combination of Carbopol (C) and methyl cellulose (MC), was carried out at two different pH (4.0 and 7.4) and temperatures (25 and 37 degrees C) by rotational cone and plate viscometry. The shear stress (tau) vs. shear rate (D) flow curves of the aqueous polymer solutions indicated a pseudoplastic behavior, with a yield point. An increase in pH from 4.0 to 7.4, or temperature from 25 to 37 degrees C, resulted in an increase in viscosity (eta), tau, and yield point, the magnitude of changes being highest when both the parameters were altered simultaneously. An increase in concentration of either C or MC, or an increase in MC molecular weight results in an increase in eta, tau, and yield point. Among the compositions studied, a solution containing 1.5% MC 0.3% C was found to have low eta, and formed a strong gel under simulated physiological conditions. Such a system can be formulated as drug containing liquid suitable for administration by instillation into the eye, which upon exposure to physiological conditions will shift to the gel (semi-solid) phase, thus increasing the precorneal residence time of the delivery system and enhancing ocular bioavailability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207344     DOI: 10.1089/jop.1994.10.47

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  9 in total

1.  Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation.

Authors:  Sabyasachi Maiti; Sayon Paul; Ranjit Mondol; Somasree Ray; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2011-06-14       Impact factor: 3.246

2.  Enhancement of scleral macromolecular permeability with prostaglandins.

Authors:  R N Weinreb
Journal:  Trans Am Ophthalmol Soc       Date:  2001

3.  Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response.

Authors:  SivaNaga S Anumolu; Yashveer Singh; Dayuan Gao; Stanley Stein; Patrick J Sinko
Journal:  J Control Release       Date:  2009-03-31       Impact factor: 9.776

4.  Mucoadhesive drug delivery system: An overview.

Authors:  Bindu M Boddupalli; Zulkar N K Mohammed; Ravinder A Nath; David Banji
Journal:  J Adv Pharm Technol Res       Date:  2010-10

5.  In vivo drug delivery via contact lenses: The current state of the field from origins to present.

Authors:  Liana D Wuchte; Stephen A DiPasquale; Mark E Byrne
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-18       Impact factor: 5.062

6.  Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel.

Authors:  Dinesh Kumar Pandurangan; Prathima Bodagala; Vijayaraj Kumar Palanirajan; Saravanan Govindaraj
Journal:  Int J Pharm Investig       Date:  2016 Jan-Mar

Review 7.  Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview.

Authors:  Elena Giuliano; Donatella Paolino; Massimo Fresta; Donato Cosco
Journal:  Pharmaceutics       Date:  2018-09-12       Impact factor: 6.321

Review 8.  Glaucoma Treatment and Hydrogel: Current Insights and State of the Art.

Authors:  Antonio Maria Fea; Cristina Novarese; Paolo Caselgrandi; Giacomo Boscia
Journal:  Gels       Date:  2022-08-17

9.  Nanoparticles laden in situ gelling system for ocular drug targeting.

Authors:  Divya Kumar; Nidhi Jain; Neha Gulati; Upendra Nagaich
Journal:  J Adv Pharm Technol Res       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.